About the Company
Tilray is a Canadian pharmaceutical and cannabis firm based in Toronto, Ontario, that was founded in the United States. Tilray has subsidiaries in Australia, New Zealand, Germany, Portugal, and Latin America. The firm announced a merger with Aphria in December 2020, and it would trade on NASDAQ and the Toronto Stock Exchange under the Tilray name and ticker symbol. Tilray, was founded in 2014, was initially established under the umbrella of Seattle-based Privateer Holdings. Tilray was recognized for excellent manufacturing standards in December 2016. Tilray became the first cannabis business to trade publicly on a major U.S. stock market in July 2018, debuting on the NASDAQ exchange. The IPO raised a total of US$153 million.;